Document is current
Any future updates will be listed below
-
Authors
Chen, Lu
Li, Wenxuan
Zai, Wenjing
Zheng, Xiangyi
Meng, Xianlong
Yao, Qunyan
Li, Wei
Liang, Ying
Ye, Mu
Zhou, Kaicheng
Liu, Mengxing
Yang, Zhicong
Mao, Zhanrui
Wei, Hongyan
Yang, Shuai
Shi, Guoming
Yuan, Zhenghong
Yu, Wenqiang
-
Funding
Funding for this research was provided by:
Shanghai Sailing Program (23YF1445600)
National Natural Science Foundation of China (3227040393)
Major Special Projects of Basic Research of Shanghai Science and Technology Commission (18JC1411101)
- License Information
-
More Information
Article History
Received: 8 March 2025
Accepted: 9 May 2025
First Online: 22 May 2025
Declarations
:
: All animal experiments were approved by the Fudan Committee on Animal Care and in compliance with ethical guidelines. The use of human serums was obtained with the approval of the Committee of Zhongshan Hospital of Fudan University. All patients provided informed consent.
: All authors agreed on the manuscript.
: Shuai Yang is the R&D Director for Shanghai Epicurer Biotechnology Co., Ltd. Wenqiang Yu serves on the Scientific Advisory Board of Epicurer. Epicurer have approved pending patents related to this work. All the other authors declare no competing interests.
